Commentary to factors predicting cardiovascular events in statin-treated diabetic and non-diabetic patients with coronary atherosclerosis.
Riesen
Walter F
WF
walter.riesen@ikch.ch
D008078:Cholesterol, LDL / Q000378:metabolism; D002986:Clinical Trials as Topic; D003324:Coronary Artery Disease / Q000378:metabolism*; D048909:Diabetes Complications / Q000175:diagnosis / Q000378:metabolism; D003920:Diabetes Mellitus / Q000378:metabolism*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008055:Lipids / Q000737:chemistry; D009525:Niacin / Q000627:therapeutic use; D012306:Risk; D012307:Risk Factors
D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008055:Lipids; D009525:Niacin